Genextra S.p.A. 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Dec 3, 2018

Insider Transaction Report

Form 4
Period: 2018-11-29
Transactions
  • Sale

    Common stock, par value $0.001 per share

    2018-11-29$105.07/sh750,000$78,802,5006,095,578 total

Documents

1 file
  • 4
    form4.xmlPrimary